RNA antagonist compounds for the modulation of FABP4/aP2

Details for Australian Patent Application No. 2008292091 (hide)

Owner Santaris Pharma A/S

Inventors Straarup, Ellen Marie; McCullagh, Keith; Nielsen, Niels Fisker

Agent FB Rice

Pub. Number AU-A-2008292091

PCT Pub. Number WO2009/027527

Priority 60/969,016 30.08.07 US

Filing date 29 August 2008

Wipo publication date 5 March 2009

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

4 March 2010 PCT application entered the National Phase

  PCT publication WO2009/027527 Priority application(s): WO2009/027527

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008292101-Prosthesis for promoting the in vivo reconstruction of a hollow organ or a portion of a hollow organ

2008292089-Method for producing a three-dimensional macroporous filament construct based on phase inversion and construct thereby obtained